Efalizumab: A Viewpoint by Jonathan J. Chan

By Chan Jonathan J.  

American Journal of Clinical Dermatology, Vol. 6, Iss. 2, 2005-01 ,pp. : 119-120

Adis International

Access to resources Recommend Favorite

Efalizumab Therapy for Psoriasis in Patients with Inadequate Responses to Etanercept

By Kramer Jesse M.  

American Journal of Clinical Dermatology, Vol. 10, Iss. 2, 2009-01 ,pp. : 134-140

Adis International

Access to resources Recommend Favorite

An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis

By Weinberg J.M.  

Clinical Therapeutics, Vol. 25, Iss. 10, 2003-10 ,pp. : 2487-2505

Elsevier

Access to resources Recommend Favorite

Efalizumab: A Review of its Use in the Management of Chronic Moderate-to-Severe Plaque Psoriasis

By Frampton James E.   Plosker Greg L.  

American Journal of Clinical Dermatology, Vol. 10, Iss. 1, 2009-01 ,pp. : 51-72

Adis International

Access to resources Recommend Favorite

Safety and Efficacy of Subcutaneously Administered Efalizumab in Adults with Moderate-to-Severe Hand and Foot Psoriasis: An Open-Label Study

By Varma Rajat   Cafardi Jennifer A.   Cantrell Wendy   Elmets Craig  

American Journal of Clinical Dermatology, Vol. 9, Iss. 2, 2008-01 ,pp. : 105-109

Adis International

Access to resources Recommend Favorite